BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 190137)

  • 1. Studies on the Epstein-Barr virus (EBV)-associated early antigen (EA) with 125 I-labelled IgG.
    Ernberg I; Brown TD
    IARC Sci Publ (1971); 1975; (11 Pt 1):339-44. PubMed ID: 190137
    [No Abstract]   [Full Text] [Related]  

  • 2. Detection of Epstein-Barr virus (EBV)-associated nuclear antigen in frozen and thawed cells and subcellular fractions of human lymphoblastoid cell lines by means of an 125I-IgG binding assay.
    Brown TD; Klein G
    IARC Sci Publ (1971); 1975; (11 Pt 1):351-6. PubMed ID: 190139
    [No Abstract]   [Full Text] [Related]  

  • 3. Detection of Epstein-Barr virus (EBV)-associated nuclear antigen in human lymphoblastoid cell lines by means of an 125-I-IgG-binding assay.
    Brown TD; Ernberg I; Lamon EW; Klein G
    Int J Cancer; 1974 Jun; 13(6):785-94. PubMed ID: 4368574
    [No Abstract]   [Full Text] [Related]  

  • 4. Native early antigen of Epstein-Barr virus, a promising antigen for diagnosis of nasopharyngeal carcinoma.
    Paramita DK; Fachiroh J; Artama WT; van Benthem E; Haryana SM; Middeldorp JM
    J Med Virol; 2007 Nov; 79(11):1710-21. PubMed ID: 17854043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoradiographic detection of Epstein-Barr virus (EBV)-associated early antigen in a variety of EBV DNA-containing lymphoblastoid cell lines previously designated as nonproducers.
    Moar MH; Siegert W; Klein G
    Intervirology; 1978; 9(6):333-43. PubMed ID: 204604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of the Epstein-Barr virus-associated antigens EA (early antigen) and VCA (viral capsid antigen) by direct or indirect binding of iodinated antibodies to antigen immobilized in polyacrylamide gel.
    Dölken G; Moar MH; Klein G
    Eur J Cancer (1965); 1979 May; 15(5):821-4. PubMed ID: 228942
    [No Abstract]   [Full Text] [Related]  

  • 7. Detection of Epstein-Barr virus-determined intracellular antigens in unfixed cells with labeled antibodies.
    Hilgers F; Rosén A; Lamon E; Klein G
    J Natl Cancer Inst; 1974 Oct; 53(4):949-55. PubMed ID: 4372371
    [No Abstract]   [Full Text] [Related]  

  • 8. [Demonstration of IgG- and IgA-antibodies against Epstein-Barr virus-associated antigens with a microtiter enzyme immunoassay system. The determination of serum antibodies against the viral capsid antigen and the early antigen complex in the sera of tumor and infectious mononucleosis patients].
    Dölken G; Bitzer M; Bross KJ; Brugger W; Boldt C; Hirsch FW; Weitzmann U; Löhr GW
    Dtsch Med Wochenschr; 1984 Nov; 109(48):1837-43. PubMed ID: 6094138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of Epstein-Barr virus (EBV) antigens II. Detection of early antigen (S) using anticomplement immunofluorescence (ACIF) et complement fixation (CF) tests.
    Lenoir G; Berthelon MC; Favre MC; De-Thé G
    Biomedicine; 1975 Dec; 23(10):461-4. PubMed ID: 177116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High incidence of elevated antibody titers to Epstein-Barr virus in patients with uveitis.
    Touge C; Agawa H; Sairenji T; Inoue Y
    Arch Virol; 2006 May; 151(5):895-903. PubMed ID: 16362642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct patterns of viral antigen expression in Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus coinfected body-cavity-based lymphoma cell lines: potential switches in latent gene expression due to coinfection.
    Callahan J; Pai S; Cotter M; Robertson ES
    Virology; 1999 Sep; 262(1):18-30. PubMed ID: 10489337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibodies to Epstein-Barr virus in nasopharyngeal carcinoma, tonsillar carcinoma and control groups.
    Oberender H; Nowak R; Donner A; Kunkel M; Gärtner L; Scholtz HJ
    Acta Virol; 1983 May; 27(3):277-81. PubMed ID: 6138990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of immunity to Epstein-Barr virus in Malaysian children.
    Yadav MS; Malliga N; Ablashi DV
    Microbiologica; 1987 Jan; 10(1):29-35. PubMed ID: 3033449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-assay combination of Epstein-Barr Virus (EBV) EBNA1- and viral capsid antigen-p18-derived synthetic peptides for measuring anti-EBV immunoglobulin G (IgG) and IgA antibody levels in sera from nasopharyngeal carcinoma patients: options for field screening.
    Fachiroh J; Paramita DK; Hariwiyanto B; Harijadi A; Dahlia HL; Indrasari SR; Kusumo H; Zeng YS; Schouten T; Mubarika S; Middeldorp JM
    J Clin Microbiol; 2006 Apr; 44(4):1459-67. PubMed ID: 16597877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein-Barr virus (EBV) replication and expressions of EA-D (BMRF1 gene product), virus-specific deoxyribonuclease, and DNA polymerase in EBV-activated Akata cells.
    Daibata M; Sairenji T
    Virology; 1993 Oct; 196(2):900-4. PubMed ID: 8396819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoradiographic detection of the Epstein-Barr virus (EBV)-associated early antigen (EA) in lymphoblastoid cell lines.
    Moar MH; Siegert W; Klein G
    Haematol Blood Transfus; 1977; 20():283-7. PubMed ID: 204549
    [No Abstract]   [Full Text] [Related]  

  • 17. Radioiodine-labeled antibody test for the detection of membrane antigens associated with Epstein-Barr virus.
    Hewetson JF; Gothoskar B; Klein G
    J Natl Cancer Inst; 1972 Jan; 48(1):87-94. PubMed ID: 4347031
    [No Abstract]   [Full Text] [Related]  

  • 18. [Evaluation of IgG and IgA type antibodies to capsid and early antigens of the Epstein-Barr virus in the diagnosis of nasopharyngeal carcinoma].
    Mendoza J; Rojas A; de la Rosa M; Amador JM; Expósito J; Esquivias J
    Med Clin (Barc); 1991 Nov; 97(16):609-11. PubMed ID: 1662737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Epstein-Barr virus-specific immunity in asymptomatic carriers of human T-cell leukemia virus type 1].
    Kwon KW
    Hokkaido Igaku Zasshi; 1995 Mar; 70(2):315-28. PubMed ID: 7774883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Performance of the VIDAS automated immunoassay for the determination of Epstein-Barr virus serological status].
    De Ory F; Guisasola ME; Sanz JC; García-Bermejo I
    Enferm Infecc Microbiol Clin; 2012 Dec; 30(10):618-20. PubMed ID: 22854635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.